Related Experiment Video
Updated: Jan 27, 2026

Barnes Maze Testing Strategies with Small and Large Rodent Models
Published on: February 26, 2014
Abstract:
Dual inhibition of autophagy and KRAS signaling shows promise in mouse models of pancreatic cancer, prompting trials in human patients.
Insights
Dual inhibition of autophagy and KRAS signaling is a promising strategy for pancreatic cancer treatment. This approach has shown success in mouse models and is now being tested in human clinical trials.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Pancreatic ductal adenocarcinoma (PDAC) remains a challenging malignancy with limited therapeutic options.
- KRAS mutations are prevalent in PDAC and drive tumor progression.
- Autophagy, a cellular degradation process, is often dysregulated in cancer and can promote tumor survival.
Related Concept Videos
In Vitro Drug Dissolution: Compendial Testing Models I
In Vitro Drug Dissolution: Compendial Testing Models II
In Vitro Drug Release Testing: Overview, Development and Validation
Persuasion Strategies
Coping Strategies: Problem Focused
For example, consider a student who struggles to understand their...
Strategies of Self-Presentation II: Self-Verification

